Abel Robert Lorne 4
4 · Schrodinger, Inc. · Filed Sep 14, 2021
Insider Transaction Report
Form 4
Abel Robert Lorne
See Remarks
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-09-13−15,602→ 110,357 totalExercise: $17.00Exp: 2030-02-05→ Common Stock (15,602 underlying) - Sale
Common Stock
2021-09-13$61.09/sh−5,820$355,539→ 9,782 total - Exercise/Conversion
Common Stock
2021-09-13$17.00/sh+15,602$265,234→ 15,602 total - Sale
Common Stock
2021-09-13$62.14/sh−9,782$607,896→ 0 total
Footnotes (4)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.65 to $61.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (3) of this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.73 to $62.63, inclusive.
- [F4]This option was granted on February 5, 2020. The shares underlying the option vested with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.